glp-1 or metformin Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies Baseline characteristics of GLP-1 and

10.2337/db14-1708 128

Combination of BPC-157 + TB-500: documented synergy in preclinical studies for multi-tissue repair

36(4): 132330 Chiechio S, Copani A, Nicoletti F, et al

It is helpful to have some smaller pieces of wood to catch the larger pieces on fire first

Studies that include patients who are considered at-risk (i.e., diabetics, cardiac, elderly, etc.) and are currently taking GLP-1 RAs should also be performed as these patients may have compounding risk during the perioperative period which may make them more susceptible to complications related to GLP-1 use (Santos et al

Thus, even if additive or synergistic effects between iSGLT2 use and fasting remain to be established, their individual benefits and preliminary safety data support further exploration